专利信息

首页 1 2 3 4 5 6 下页尾页共 185 条记录, 当前第1/19页。

专利标题：Targeted liposomes

专利权人：Georgetown University;

The present invention is in the field of drug delivery and specifically cationic liposome-based drug delivery. In embodiments this invention provides methods of making ligand-targeted (e.g. antibody- or antibody fragment-targeted) liposomes useful for the delivery of liposomes to tumors including brain tumors. In embodiments the liposomes deliver temozolomide across the blood-brain barrier for treatment of primary or metastatic brain tumors. Additional cancers that can be treated with the liposo...

专利标题：The preparation method of pharmaceutical grade melphalan and hydrochloric acid one salt thereof, disalt

专利标题：Process of making optically pure melphalan

专利权人：NAVINTA LLC;

This invention provides a process of making optically pure melphalan of the formula by hydroxyethylation in a regioselective manner of the aromatic amino group rather than the glycinic amino group.

专利标题：99mtco nuclear mark melphalan dithiocarbamate complexes and preparation method and application

专利权人：Beijing Normal University;

专利标题：The new melphalan derivatives, processes for their preparation, pharmaceutical composition containing them and the medical use

专利标题：Histone deacetylase (hdac) inhibitors (pxd101) for the treatment of cancer alone or in combination with chemotherapeutic agent

专利权人：Topotarget Uk Limited;

The present invention relates generally to methods for treating cancer. In one respect the present invention relates to a method of treating a hematological cancer (e.g. multiple myeloma leukemia lymphoma) comprising administering to a patient in need thereof a therapeutically effective amount of a histone deacetylase inhibitor for example a histone deacetylase (HDAC) inhibitor as described herein for example PXD-101. In another respect the present invention relates to a method of treating cance...

专利标题：Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent

专利权人：Topotarget Uk Limited;

专利标题：INJECTABLE PHARMACEUTICAL FORMULATION OF MELPHALAN

专利权人：ERIOCHEM S A [AR];

An injectable pharmaceutical formulation of Melphalan comprising a solid composition of melphalan hydrochloride lyophilized with a content of impurities up to 1.3 % (p/p)and a pH buffer solution

专利标题：INJECTABLE PHARMACEUTICAL FORMULATION OF MELPHALAN

An injectable pharmaceutical formulation of Melphalan comprising a solid composition of melphalan hydrochloride lyophilized with a content of impurities up to 1.3% (p/p)and a pH buffer solution

专利标题：Injectable pharmaceutical formulation of melphalan

专利权人：Eriochem;

An injectable pharmaceutical formulation of Melphalan comprising a solid composition of melphalan hydrochloride lyophilized with a content of impurities up to 1.3% (p/p)and a pH buffer solution; a process to prepare said solid composition. Also a reconstituted solution of melphalan comprising a solid composition of melphalan lyophilized reconstituted wherein said solution is aqueous a perfusion free of organic solvent and a kit.

当前查询条件: [药品] 包含 'Melphalan '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. EP2711000A1	2014/3/26	EP20130156234	2013/2/21
专利标题：Targeted liposomes 专利权人：Georgetown University; The present invention is in the field of drug delivery and specifically cationic liposome-based drug delivery. In embodiments this invention provides methods of making ligand-targeted (e.g. antibody- or antibody fragment-targeted) liposomes useful for the delivery of liposomes to tumors including brain tumors. In embodiments the liposomes deliver temozolomide across the blood-brain barrier for treatment of primary or metastatic brain tumors. Additional cancers that can be treated with the liposo...

2. CN102030671B	2014/2/19
专利标题：The preparation method of pharmaceutical grade melphalan and hydrochloric acid one salt thereof, disalt 专利权人：Zhejiang Chempacific Chemical Co., Ltd.;

3. US8575385B2	2013/11/5
专利标题：Process of making optically pure melphalan 专利权人：NAVINTA LLC; This invention provides a process of making optically pure melphalan of the formula by hydroxyethylation in a regioselective manner of the aromatic amino group rather than the glycinic amino group.

4. CN102167711B	2013/8/7
专利标题：99mtco nuclear mark melphalan dithiocarbamate complexes and preparation method and application 专利权人：Beijing Normal University;

5. PL397663A1	2013/7/8	PL20110397663	2011/12/30
专利标题：The new melphalan derivatives, processes for their preparation, pharmaceutical composition containing them and the medical use 专利权人：INST BIOTECHNOLOGII I ANTYBIOTYKOW [PL];

6. AU2006313517B2	2013/6/27	AU20060313517	2006/11/10
专利标题：Histone deacetylase (hdac) inhibitors (pxd101) for the treatment of cancer alone or in combination with chemotherapeutic agent 专利权人：Topotarget Uk Limited; The present invention relates generally to methods for treating cancer. In one respect the present invention relates to a method of treating a hematological cancer (e.g. multiple myeloma leukemia lymphoma) comprising administering to a patient in need thereof a therapeutically effective amount of a histone deacetylase inhibitor for example a histone deacetylase (HDAC) inhibitor as described herein for example PXD-101. In another respect the present invention relates to a method of treating cance...

7. AU2013205999A1	2013/6/13	AU20130205999	2013/5/23
专利标题：Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent 专利权人：Topotarget Uk Limited; The present invention relates generally to methods for treating cancer. In one respect the present invention relates to a method of treating a hematological cancer (e.g. multiple myeloma leukemia lymphoma) comprising administering to a patient in need thereof a therapeutically effective amount of a histone deacetylase inhibitor for example a histone deacetylase (HDAC) inhibitor as described herein for example PXD-101. In another respect the present invention relates to a method of treating cance...

8. EP2599484A1	2013/6/5	EP20110803180	2011/7/4
专利标题：INJECTABLE PHARMACEUTICAL FORMULATION OF MELPHALAN 专利权人：ERIOCHEM S A [AR]; An injectable pharmaceutical formulation of Melphalan comprising a solid composition of melphalan hydrochloride lyophilized with a content of impurities up to 1.3 % (p/p)and a pH buffer solution

9. US2013131174A1	2013/5/23	US201113808728	2011/7/4
专利标题：INJECTABLE PHARMACEUTICAL FORMULATION OF MELPHALAN 专利权人：CASTILLO JOSE [AR];ITURRASPE JOSE BERNARDO [AR];NUNEZ JOSE LUCIO [AR];ERIOCHEM [AR]; An injectable pharmaceutical formulation of Melphalan comprising a solid composition of melphalan hydrochloride lyophilized with a content of impurities up to 1.3% (p/p)and a pH buffer solution

10. US20130131174A1	2013/5/23
专利标题：Injectable pharmaceutical formulation of melphalan 专利权人：Eriochem; An injectable pharmaceutical formulation of Melphalan comprising a solid composition of melphalan hydrochloride lyophilized with a content of impurities up to 1.3% (p/p)and a pH buffer solution; a process to prepare said solid composition. Also a reconstituted solution of melphalan comprising a solid composition of melphalan lyophilized reconstituted wherein said solution is aqueous a perfusion free of organic solvent and a kit.

下载范围

下载内容